Q-omics provides the consensus-scored RNA5SP222 profile across patient tissues and cancer cell-line models. RNA5SP222 expression is associated with patient survival in 5 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, RNA5SP222 RNA expression shows 5,467 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight KIRC, and ESCA as cancer lineages where RNA5SP222 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.